Occurrence of hepatitis B and C infection in pediatric patients with cancer at Alhadbaa Hospital in Mosul/Iraq

Hepatitis B and C in Pediatric Cancer Patients in Mosul

Authors

  • Dhelal Ahmad Theyab Al-jumaily department of internal medicine, college of medicine, Ninevah University
  • Shiama Mohammad nory CABP , Alhadbaa Blood Disease Hospital ,Oncology unit, Mosul ,Iraq.
  • Yasir Saadoon Algele CABP , Alhadbaa Blood Disease Hospital ,Oncology unit, Mosul ,Iraq.

DOI:

https://doi.org/10.29409/20hcxw96

Keywords:

Pediatric oncology, Hepatitis B and C virus, Blood transfusion, Vaccination failure, iraq

Abstract

Pediatric cancer patients face increased susceptibility to hepatitis B and C virus infection owing to immunosuppression resulting from the disease and its treatment, the frequent need for blood transfusions, and invasive procedures. This study sought to determine the prevalence of HBV and HCV infection within this community and identify correlated risk variables.

Cohort research was performed in the oncology unit of Alhadbaa Teaching Hospital in Mosul from December 1, 2014, to December 1, 2024. The study included 153 children (under 15 years) with cancer selected randomly for routine checkup at the outpatient clinic who were initially negative for HBV and HCV at diagnosis, and screening was performed every 3 months for HBV and HCV. Demographic data, cancer type, vaccination status (both routine and postdiagnosis), and blood transfusion history were collected.

Results: Over a follow-up duration of 10 years, all the children remained in follow-up, largely because of their families’ strong commitment to monitoring their health status, given the diagnosis of cancer. Twelve patients (7.8%) seroconverted to HBV-positive, and 2 patients (1.3%) acquired hepatitis C virus (HCV), culminating in a total incidence of hepatotropic viruses of 9.1%. Although higher proportions of HBV infection were observed among children who underwent blood transfusions and those who were unvaccinated or inadequately vaccinated, these associations did not reach statistical significance. The infection rate decreased relative to that reported in prior trials conducted in other countries. These results strongly support the stringent enforcement of universal blood product screening and meticulous aseptic procedures, importantly, at the time of cancer diagnosis for unvaccinated children.

Conclusion: This study revealed that the prevalence of hepatitis B infection among pediatric cancer patients in Mosul was not significantly associated with frequent blood transfusions and insufficient immunization coverage.

References

1. Al‑Jumaily U, Abdulmunem AE, Abbood O. Incidence of hepatitis B and C in children with cancer: a single institution experience in Iraq. Texas J Med Sci. 2022;15:146‑153.

2. Rogers LJ, Vaja R, ,Smith T,PatelM,LeeH. Hepatitis B virus reactivation in cancer patients receiving chemotherapy: a systematic review and meta-analysis .Semin Oncol2024;51(5-6):123-134.

3. Shah D, Jain H, KumerP, SinghA,GuptaR,etal. Hepatitis B reactivation without hepatitis is a common event in adolescent/adult ALL patients with occult HBV treated on pediatric protocols: a prospective cohort study. Blood. 2023;142(Suppl 1):1459.

4 .Pokorska‑Śpiewak M, Marczyńska M. HBV and HCV infection in children and adolescents. Vaccines. 2023;11(2):330.

5. Savaliva BP, Shekouhi R, Mubarak F,Al-Hussainy M, et al. Risk of hepatitis B virus reactivation in cancer patients undergoing treatment with tyrosine kinase inhibitors. World J Gastroenterol. 2024;30(24):3052‑3058.

6. Tonnini M, Solera Horna C, Jelasi L,etal . Prevention of hepatitis B reactivation in patients with hematologic malignancies treated with novel systemic therapies: who and why? World J Gastroenterol. 2024;30(5):509‑511.

7. Xia Z, Zhang J, Chen W,Li Y,WangH, et al. Hepatitis B reactivation in cancer patients receiving immune checkpoint inhibitors: systematic review and meta‑analysis. Infect Dis Poverty. 2023;12:87.

8. Al Sadeq DW, Majdalawish AF, Nasrallah GK. Seroprevalence and incidence of hepatitis E virus among blood donors: a review. Rev Med Virol. 2017;40(2):659‑664.

9. Al‑Jadiry MF, Al‑Khafagi M, Al‑Darraji AF, et al. High incidence of hepatitis B infection after treatment for pediatric cancer at a teaching hospital in Baghdad. East Mediterr Health J. 2013;19(2):130‑134.

10. Păcurar D, Dinulescu A, Jugulete G, et al. Hepatitis B in pediatric population: observational retrospective study in Romania. Life (Basel). 2024;14(3):348.

Additional Files

Received

09-10-2025

Revised

28-12-2025

Accepted

31-12-2025

Published

31-12-2025

Data Availability Statement

The datasets generated and/or analyzed during the current study are not publicly available due to patient confidentiality regulations but are available from the corresponding author upon reasonable request and with permission from the relevant institutional authority.

 

Issue

Section

Cancer Research

How to Cite

Al-jumaily , . D. A. T. ., nory, S. M., & Yasir Saadoon Algele. (2025). Occurrence of hepatitis B and C infection in pediatric patients with cancer at Alhadbaa Hospital in Mosul/Iraq: Hepatitis B and C in Pediatric Cancer Patients in Mosul. Iraqi Journal of Cancer and Medical Genetics, 18(2), 33-37. https://doi.org/10.29409/20hcxw96

Similar Articles

11-20 of 149

You may also start an advanced similarity search for this article.